177 related articles for article (PubMed ID: 11508855)
21. Expression of BRCA1 and BRCA2 in normal and neoplastic cells.
Chodosh LA
J Mammary Gland Biol Neoplasia; 1998 Oct; 3(4):389-402. PubMed ID: 10819533
[TBL] [Abstract][Full Text] [Related]
22. Distinct transcription start sites generate two forms of BRCA1 mRNA.
Xu CF; Brown MA; Chambers JA; Griffiths B; Nicolai H; Solomon E
Hum Mol Genet; 1995 Dec; 4(12):2259-64. PubMed ID: 8634696
[TBL] [Abstract][Full Text] [Related]
23. Brca1 expression is regulated by a bidirectional promoter that is shared by the Nbr1 gene in mouse.
Whitehouse C; Chambers J; Catteau A; Solomon E
Gene; 2004 Feb; 326():87-96. PubMed ID: 14729266
[TBL] [Abstract][Full Text] [Related]
24. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
Esteller M; Silva JM; Dominguez G; Bonilla F; Matias-Guiu X; Lerma E; Bussaglia E; Prat J; Harkes IC; Repasky EA; Gabrielson E; Schutte M; Baylin SB; Herman JG
J Natl Cancer Inst; 2000 Apr; 92(7):564-9. PubMed ID: 10749912
[TBL] [Abstract][Full Text] [Related]
25. BRCA1 and prostate cancer.
Rosen EM; Fan S; Goldberg ID
Cancer Invest; 2001; 19(4):396-412. PubMed ID: 11405179
[TBL] [Abstract][Full Text] [Related]
26. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents.
Andres JL; Fan S; Turkel GJ; Wang JA; Twu NF; Yuan RQ; Lamszus K; Goldberg ID; Rosen EM
Oncogene; 1998 Apr; 16(17):2229-41. PubMed ID: 9619832
[TBL] [Abstract][Full Text] [Related]
27. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
[TBL] [Abstract][Full Text] [Related]
28. Quantitative analysis of BRCA1 and BRCA2 mRNA expression in sporadic breast carcinomas and its relationship with clinicopathological characteristics.
Egawa C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Jpn J Cancer Res; 2001 Jun; 92(6):624-30. PubMed ID: 11429050
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of human ferritin H chain gene in immortal human breast epithelial MCF-10F cells.
Higgy NA; Salicioni AM; Russo IH; Zhang PL; Russo J
Mol Carcinog; 1997 Dec; 20(4):332-9. PubMed ID: 9433477
[TBL] [Abstract][Full Text] [Related]
30. BRCA1 expression during prenatal development of the human mammary gland.
Magdinier F; Dalla Venezia N; Lenoir GM; Frappart L; Dante R
Oncogene; 1999 Jul; 18(27):4039-43. PubMed ID: 10435628
[TBL] [Abstract][Full Text] [Related]
31. Transcription of BRCA1 is dependent on the formation of a specific protein-DNA complex on the minimal BRCA1 Bi-directional promoter.
Suen TC; Goss PE
J Biol Chem; 1999 Oct; 274(44):31297-304. PubMed ID: 10531328
[TBL] [Abstract][Full Text] [Related]
32. Embryonic mammary signature subsets are activated in Brca1-/- and basal-like breast cancers.
Zvelebil M; Oliemuller E; Gao Q; Wansbury O; Mackay A; Kendrick H; Smalley MJ; Reis-Filho JS; Howard BA
Breast Cancer Res; 2013 Mar; 15(2):R25. PubMed ID: 23506684
[TBL] [Abstract][Full Text] [Related]
33. The DeltaNp63 proteins are key allies of BRCA1 in the prevention of basal-like breast cancer.
Buckley NE; Conlon SJ; Jirstrom K; Kay EW; Crawford NT; O'Grady A; Sheehan K; Mc Dade SS; Wang CW; McCance DJ; Johnston PG; Kennedy RD; Harkin DP; Mullan PB
Cancer Res; 2011 Mar; 71(5):1933-44. PubMed ID: 21363924
[TBL] [Abstract][Full Text] [Related]
34. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
[TBL] [Abstract][Full Text] [Related]
35. BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells.
Vaughn JP; Davis PL; Jarboe MD; Huper G; Evans AC; Wiseman RW; Berchuck A; Iglehart JD; Futreal PA; Marks JR
Cell Growth Differ; 1996 Jun; 7(6):711-5. PubMed ID: 8780884
[TBL] [Abstract][Full Text] [Related]
36. ΔNp63α induces quiescence and downregulates the BRCA1 pathway in estrogen receptor-positive luminal breast cancer cell line MCF7 but not in other breast cancer cell lines.
Amin R; Morita-Fujimura Y; Tawarayama H; Semba K; Chiba N; Fukumoto M; Ikawa S
Mol Oncol; 2016 Apr; 10(4):575-93. PubMed ID: 26704768
[TBL] [Abstract][Full Text] [Related]
37. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells.
Gudas JM; Li T; Nguyen H; Jensen D; Rauscher FJ; Cowan KH
Cell Growth Differ; 1996 Jun; 7(6):717-23. PubMed ID: 8780885
[TBL] [Abstract][Full Text] [Related]
38. RNA analysis reveals splicing mutations and loss of expression defects in MLH1 and BRCA1.
Sharp A; Pichert G; Lucassen A; Eccles D
Hum Mutat; 2004 Sep; 24(3):272. PubMed ID: 15300854
[TBL] [Abstract][Full Text] [Related]
39. BRCA1 tumour suppression occurs via heterochromatin-mediated silencing.
Zhu Q; Pao GM; Huynh AM; Suh H; Tonnu N; Nederlof PM; Gage FH; Verma IM
Nature; 2011 Sep; 477(7363):179-84. PubMed ID: 21901007
[TBL] [Abstract][Full Text] [Related]
40. Localization of the VHR phosphatase gene and its analysis as a candidate for BRCA1.
Kamb A; Futreal PA; Rosenthal J; Cochran C; Harshman KD; Liu Q; Phelps RS; Tavtigian SV; Tran T; Hussey C
Genomics; 1994 Sep; 23(1):163-7. PubMed ID: 7829067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
